Oracle Healthcare Translational Research 4.1.0/4.1.1 DataStudio cleartext transmission
| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 8.9 | $5k-$25k | 0.00 |
Summary
A vulnerability, which was classified as very critical, has been found in Oracle Healthcare Translational Research 4.1.0/4.1.1. Impacted is an unknown function of the component DataStudio. Performing a manipulation results in an unknown weakness. This vulnerability is known as CVE-2023-23914. Remote exploitation of the attack is possible. No exploit is available.
Details
A vulnerability, which was classified as very critical, was found in Oracle Healthcare Translational Research 4.1.0/4.1.1 (Medical Device Software). This affects an unknown functionality of the component DataStudio. CWE is classifying the issue as CWE-319. The product transmits sensitive or security-critical data in cleartext in a communication channel that can be sniffed by unauthorized actors. This is going to have an impact on confidentiality, and integrity.
The weakness was published 04/18/2023 as Oracle Critical Patch Update Advisory - April 2023. The advisory is shared at oracle.com. This vulnerability is uniquely identified as CVE-2023-23914. Neither technical details nor an exploit are publicly available. The price for an exploit might be around USD $5k-$25k at the moment (estimation calculated on 05/12/2023). MITRE ATT&CK project uses the attack technique T1040 for this issue.
We expect the 0-day to have been worth approximately $25k-$100k.
A possible mitigation has been published immediately after the disclosure of the vulnerability.
If you want to get the best quality for vulnerability data then you always have to consider VulDB.
Product
Type
Vendor
Name
Version
License
Website
- Vendor: https://www.oracle.com
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔍VulDB Reliability: 🔍
CVSSv3
VulDB Meta Base Score: 9.1VulDB Meta Temp Score: 8.9
VulDB Base Score: 9.1
VulDB Temp Score: 8.7
VulDB Vector: 🔍
VulDB Reliability: 🔍
NVD Base Score: 9.1
NVD Vector: 🔍
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔍
VulDB Temp Score: 🔍
VulDB Reliability: 🔍
Exploiting
Class: Cleartext transmissionCWE: CWE-319 / CWE-310
CAPEC: 🔍
ATT&CK: 🔍
Physical: No
Local: No
Remote: Yes
Availability: 🔍
Status: Not defined
EPSS Score: 🔍
EPSS Percentile: 🔍
Price Prediction: 🔍
Current Price Estimation: 🔍
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: no mitigation knownStatus: 🔍
Reaction Time: 🔍
0-Day Time: 🔍
Exposure Time: 🔍
Timeline
01/19/2023 🔍04/18/2023 🔍
04/18/2023 🔍
04/18/2023 🔍
05/12/2023 🔍
Sources
Vendor: oracle.comAdvisory: Oracle Critical Patch Update Advisory - April 2023
Status: Confirmed
CVE: CVE-2023-23914 (🔍)
GCVE (CVE): GCVE-0-2023-23914
GCVE (VulDB): GCVE-100-226605
Entry
Created: 04/18/2023 23:17Updated: 05/12/2023 02:47
Changes: 04/18/2023 23:17 (38), 05/12/2023 02:39 (2), 05/12/2023 02:47 (12)
Complete: 🔍
Cache ID: 216:54A:103
If you want to get the best quality for vulnerability data then you always have to consider VulDB.
No comments yet. Languages: en.
Please log in to comment.